Franklin Resources’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,604,379
Closed -$1.17B 1763
2020
Q1
$1.17B Sell
6,604,379
-758,024
-10% -$143M 0.78% 22
2019
Q4
$1.41B Sell
7,362,403
-34,469
-0.5% -$6.22M 0.74% 20
2019
Q3
$1.24B Buy
7,396,872
+1,125,072
+18% +$183M 0.68% 23
2019
Q2
$1.05B Buy
6,271,800
+859,281
+16% +$119M 0.56% 37
2019
Q1
$792M Buy
5,412,519
+350,312
+7% +$50.8M 0.42% 63
2018
Q4
$677M Sell
5,062,207
-69,618
-1% -$11.4M 0.41% 66
2018
Q3
$978M Buy
5,131,825
+84,911
+2% +$15.6M 0.49% 42
2018
Q2
$841M Sell
5,046,914
-339,029
-6% -$54.4M 0.43% 54
2018
Q1
$906M Buy
5,385,943
+516,084
+11% +$86.6M 0.46% 47
2017
Q4
$797M Buy
4,869,859
+200,876
+4% +$36M 0.38% 67
2017
Q3
$957M Sell
4,668,983
-227,547
-5% -$52.9M 0.47% 47
2017
Q2
$1.19B Sell
4,896,530
-289,574
-6% -$68M 0.59% 32
2017
Q1
$1.24B Buy
5,186,104
+207,674
+4% +$48.4M 0.63% 27
2016
Q4
$1.05B Buy
4,978,430
+124,149
+3% +$25.7M 0.54% 36
2016
Q3
$1.12B Sell
4,854,281
-164,456
-3% -$40.2M 0.58% 31
2016
Q2
$1.16B Buy
5,018,737
+178,087
+4% +$41.1M 0.62% 24
2016
Q1
$1.3B Sell
4,840,650
-332,350
-6% -$95.1M 0.69% 22
2015
Q4
$1.62B Buy
5,173,000
+670,082
+15% +$199M 0.82% 16
2015
Q3
$1.22B Sell
4,502,918
-436,189
-9% -$134M 0.6% 34
2015
Q2
$1.5B Buy
4,939,107
+38,687
+0.8% +$11.5M 0.68% 22
2015
Q1
$1.46B Buy
4,900,420
+473,940
+11% +$135M 0.66% 26
2014
Q4
$1.14B Sell
4,426,480
-534,082
-11% -$133M 0.52% 41
2014
Q3
$1.2B Buy
4,960,562
+1,746,247
+54% +$391M 0.55% 38
2014
Q2
$717M Buy
3,214,315
+229,203
+8% +$47.5M 0.32% 89
2014
Q1
$614M Sell
2,985,112
-36,359
-1% -$7.2M 0.29% 96
2013
Q4
$508M Sell
3,021,471
-94,880
-3% -$14.8M 0.25% 112
2013
Q3
$449M Sell
3,116,351
-375,734
-11% -$50.1M 0.24% 118
2013
Q2
$441M Buy
+3,492,085
New +$395M 0.25% 111

Other funds holding AGN

Franklin Resources's AGN Position: Q2 2020 in Review

Franklin Resources sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,604,379 shares — an estimated $1.17B sold.

Franklin Resources first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.62B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Franklin Resources reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Franklin Resources sold 6,604,379 Allergan plc shares in Q2 2020, an estimated $1.17B.
  • Franklin Resources first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Franklin Resources's Allergan plc position peaked at $1.62B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Franklin Resources's 13F filing for Q2 2020, filed 13 Aug 2020.